Eledon pharmaceuticals inc
WebApr 13, 2024 · Eledon Pharmaceuticals Inc (ELDN) stock is down -7.38% while the S&P 500 is higher by 1.21% as of 2:09 PM on Thursday, Apr 13. ELDN is down -$0.18 from the previous closing price of $2.44 on volume of 33,925 shares. Over the past year the S&P 500 is lower by -6.86% while ELDN is down -26.14%. ELDN lost -$6.16 per share the over … WebApr 13, 2024 · Eledon Pharmaceuticals Inc (ELDN) stock is down -7.38% while the S&P 500 is higher by 1.21% as of 2:09 PM on Thursday, Apr 13. ELDN is down -$0.18 from the previous closing price of $2.44 on volume of 33,925 shares. Over the past year the S&P …
Eledon pharmaceuticals inc
Did you know?
WebMar 30, 2024 · Eledon Pharmaceuticals, Inc. (Exact name of Registrant as Specified in Its Charter) Delaware 001-36620 20-1000967 (State or Other Jurisdiction (Commission (IRS Employer of Incorporation) File ... WebApr 26, 2024 · Eledon Pharmaceuticals is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for patients living with an autoimmune disease ...
WebEledon Pharmaceuticals. Manufacturing · California, United States · <25 Employees . Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. WebMar 30, 2024 · About Eledon Pharmaceuticals and tegoprubart (formerly AT-1501) Eledon Pharmaceuticals is a clinical stage biotechnology company using its expertise in targeting the CD40 Ligand (CD40L, also called CD154) pathway to develop potential treatments for persons requiring an organ or cell-based transplant, living with autoimmune disease, or …
WebMar 23, 2024 · IRVINE, Calif., March 23, 2024 (GLOBE NEWSWIRE) -- Eledon Pharmaceuticals, Inc. (“Eledon”) (NASDAQ: ELDN) today announced that it plans to release financial results for the fourth quarter and... WebEledon Pharmaceuticals Inc (ELDN) Stock Price & News - Google Finance Home ELDN • NASDAQ Eledon Pharmaceuticals Inc Follow Share $2.10 Mar 14, 5:20:00 PM GMT-4 · USD · NASDAQ · Disclaimer...
WebApr 6, 2024 · Eledon Pharmaceuticals, Inc. filed its 10-K on Mar 30, 2024 for the period ending Dec 31, 2024. In this report its auditor, KMJ Corbin & Company LLP, gave an unqualified opinion expressing doubt that the company can continue as a going concern.
WebApr 10, 2024 · Eledon Pharmaceuticals Inc is a clinical-stage biotechnology company. The firm is focused on transplantation and autoimmune diseases. It targets CD40L pathway to develop potential treatments for patients living with an autoimmune disease, patients requiring an organ or cell-based transplant, and for patients living with ALS. 29張當票心得WebFind the latest Eledon Pharmaceuticals, Inc. (ELDN) stock quote, history, news and other vital information to help you with your stock trading and investing. 29市尺WebJul 14, 2024 · Eledon Pharmaceuticals is not a large company by global standards. It has a market capitalization of US$109m, which means it wouldn't have the attention of many institutional investors. 29度电能用多久WebEledon Pharmaceuticals Inc 's Financial Stregth Trends, Debt Coverage Ratios from the forth quarter of 2024 to forth quarter of 2024 - CSIMarket Company Name, Ticker, Customers, else.. STOCKS 29度服装WebSee the company profile for Eledon Pharmaceuticals, Inc. (ELDN) including business summary, industry/sector information, number of employees, business summary, corporate governance, key executives ... 29所招聘官网WebEledon Pharmaceuticals, Inc. is a clinical stage biotechnology company using its expertise in targeting the CD40L pathway to develop potential treatments for people undergoing organ or cellular ... 29張當票閱讀心得WebApr 5, 2024 · Operator: Greetings, and welcome to the Eledon Pharmaceuticals Fourth Quarter and Full-Year 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode. - Part 3 29式太极剑